Subscribe to Newsletter

Kelly Chibale

The Power List 2020 – Small Molecules

Neville Isdell Chair in African-centric Drug Discovery & Development and South Africa Research Chair in Drug Discovery

As director and founder of H3D, a research and development centre at the University of Cape Town, Chibale is dedicated to dispelling afro pessimism – including the idea that Africa has nothing to contribute to the global economy. Chibale’s research focuses on delivering treatment options for tuberculosis and malaria that are both safe and affordable while also creating jobs.

“I believe polypharmacology will go a long way to address and delay the emergence of drug resistance arising from mutations in a single target. It will also have the added advantage of benefiting patients by minimizing the pill burden and cost associated with combination drug regimens which currently require two or more small molecules that inhibit different single targets to be combined."

Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine